These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 6379106)

  • 1. In vitro tumoricidal activity of immunoadsorbed leukemic serum.
    Miller WJ; Branda RF
    J Biol Response Mod; 1984; 3(3):231-4. PubMed ID: 6379106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein A adsorption of acute myelogenous leukemia serum induces in vitro blast lysis.
    Miller WJ; Branda RF; Hurd DD; Wachsman W; Nelson NL; Jacob HS
    Blood; 1982 Jun; 59(6):1344-7. PubMed ID: 7044448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further characterization of the in vitro tumoricidal activity of staphylococcal protein A.
    Branda RF; Miller WJ; Soltis RD
    Cancer Res; 1986 May; 46(5):2610-3. PubMed ID: 3698001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of frequency of plasma adsorption over protein A-containing Staphylococcus aureus on regression of rat mammary adenocarcinomas: modification of antitumor immune response and tumor histopathology.
    Ray PK; Mohammed J; Allen P; Raychaudhuri S; Dohadwala M; Bandyopadhyay S; Mark R
    J Biol Response Mod; 1984; 3(1):39-59. PubMed ID: 6707699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leptin in human acute myelogenous leukemia: studies of in vivo levels and in vitro effects on native functional leukemia blasts.
    Bruserud Ø; Huang TS; Glenjen N; Gjertsen BT; Foss B
    Haematologica; 2002 Jun; 87(6):584-95. PubMed ID: 12031914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of staphylococcal protein A-treated human leukemic serum on autologous leukemic blast growth and mitogenesis of lymphocytes.
    Spitzer TR; Lazarus HM
    J Clin Immunol; 1984 Nov; 4(6):455-60. PubMed ID: 6392315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inability to demonstrate lytic antibodies to autologous leukaemia cells in the sera from remission patients with acute myelogenous leukaemia treated with active specific immunotherapy.
    Chapuis BJ; Powles R; Alexander P
    Clin Exp Immunol; 1978 May; 32(2):253-8. PubMed ID: 276431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surface immunoglobulins are involved in the interaction of protein A with human B cells and in the triggering of B cell proliferation induced by protein A-containing Staphylococcus aureus.
    Romagnani S; Giudizi MG; Biagiotti R; Almerigogna F; Maggi E; Del Prete G; Ricci M
    J Immunol; 1981 Oct; 127(4):1307-13. PubMed ID: 6974188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical grade expansion of CD45RA, CD45RO, and CD62L-positive T-cell lines from HLA-compatible donors: high cytotoxic potential against AML and ALL cells.
    Barbui AM; Borleri G; Conti E; Ciocca A; Salvi A; Micò C; Introna M; Rambaldi A
    Exp Hematol; 2006 Apr; 34(4):475-85. PubMed ID: 16569594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of death (CD95/FAS), activation and adhesion (CD54) molecules on blast cells of acute myelogenous leukemias by TNF-alpha and IFN-gamma.
    Munker R; Andreeff M
    Cytokines Mol Ther; 1996 Sep; 2(3):147-59. PubMed ID: 9384699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma therapy of primary rat mammary carcinoma: antitumor activity of tumor-bearer plasma adsorbed against inactivated CNBr sepharose or protein A-sepharose.
    Sukumar S; Zbar B; Terata N; Langone JJ
    J Biol Response Mod; 1984; 3(3):303-15. PubMed ID: 6379113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antileukemia activity of a natural killer cell line against human leukemias.
    Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
    Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the ability of monoclonal antibodies to selectively mediate complement-dependent cytotoxicity of human myelogenous leukemia blast cells.
    Ball ED; Kadushin JM; Schacter B; Fanger MW
    J Immunol; 1982 Mar; 128(3):1476-81. PubMed ID: 6948897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of the concentration of autologous serum for generation of leukemic dendritic cells from acute myeloid leukemic cells for clinical immunotherapy.
    Choi BH; Kang HK; Park JS; Kim SK; Pham TN; Zhu XW; Cho D; Nam JH; Chung IJ; Kim YJ; Rhee JH; Kim HJ; Lee JJ
    J Clin Apher; 2006 Dec; 21(4):233-40. PubMed ID: 17120232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adsorption of plasma from tumor-bearing hosts over protein A--containing nonviable Staphylococcus aureus Cowan I: possible mechanism of antitumor reactions.
    Ray PK; McLaughlin D; Allen P; Bandyopadhyay S; Idiculla A; Clarke L; Mark R; Rhoads JE; Bassett JG; Cooper DR
    J Biol Response Mod; 1984; 3(3):293-302. PubMed ID: 6379112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coculture of native human acute myelogenous leukemia blasts with fibroblasts and osteoblasts results in an increase of vascular endothelial growth factor levels.
    Glenjen NI; Hatfield K; Bruserud Ø
    Eur J Haematol; 2005 Jan; 74(1):24-34. PubMed ID: 15613103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of autologous leukemia-specific T cells in acute myeloid leukemia: monocyte-derived dendritic cells cocultured with leukemic blasts compared with leukemia-derived dendritic cells.
    Draube A; Beyer M; Wolf J
    Eur J Haematol; 2008 Oct; 81(4):281-8. PubMed ID: 18573171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of ex-vivo plasma adsorption over protein A sepharose in acute leukemia.
    Solal-Celigny P; Simeon J; Herrera A; Vinci G; Bertrand O; Mahieu P; Kinet JP; Raspaud S; Sinegre M; Boivin P
    Leuk Res; 1986; 10(6):643-9. PubMed ID: 3520164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine-driven differentiation of blasts from patients with acute myelogenous and lymphoblastic leukemia into dendritic cells.
    Köhler T; Plettig R; Wetzstein W; Schmitz M; Ritter M; Mohr B; Schaekel U; Ehninger G; Bornhäuser M
    Stem Cells; 2000; 18(2):139-47. PubMed ID: 10742386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative expression of Toll-like receptor-2, -4, and -9 in dendritic cells generated from blasts of patients with acute myeloid leukemia.
    Schmitt A; Li L; Giannopoulos K; Greiner J; Reinhardt P; Wiesneth M; Schmitt M
    Transfusion; 2008 May; 48(5):861-70. PubMed ID: 18208411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.